Icad Correlations
ICAD Stock | USD 1.54 0.01 0.65% |
The current 90-days correlation between icad inc and STRATA Skin Sciences is 0.24 (i.e., Modest diversification). The correlation of Icad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Icad Correlation With Market
Modest diversification
The correlation between icad inc and DJI is 0.24 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding icad inc and DJI in the same portfolio, assuming nothing else is changed.
Icad |
Moving together with Icad Stock
Moving against Icad Stock
0.5 | CI | Cigna Corp | PairCorr |
0.47 | ELAB | Elevai Labs, Common | PairCorr |
0.46 | EKSO | Ekso Bionics Holdings | PairCorr |
0.36 | VERO | Venus Concept | PairCorr |
0.56 | AHG | Akso Health Group | PairCorr |
0.46 | AGL | agilon health | PairCorr |
0.45 | BAX | Baxter International | PairCorr |
0.41 | ALC | Alcon AG | PairCorr |
0.4 | AMN | AMN Healthcare Services | PairCorr |
0.4 | FONR | Fonar | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Icad Stock performing well and Icad Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Icad's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
PROF | 2.13 | (0.37) | 0.00 | (0.57) | 0.00 | 4.26 | 18.74 | |||
SIBN | 2.98 | (0.44) | 0.00 | (0.11) | 0.00 | 6.75 | 27.00 | |||
SGHT | 3.06 | (1.05) | 0.00 | (0.22) | 0.00 | 6.96 | 18.22 | |||
NVRO | 3.75 | (0.46) | 0.00 | (0.10) | 0.00 | 8.28 | 25.58 | |||
FNA | 3.85 | 0.27 | 0.11 | 0.19 | 4.04 | 7.83 | 43.16 | |||
SSKN | 3.08 | 0.22 | 0.05 | 0.39 | 3.83 | 8.83 | 20.44 | |||
SIEN | 7.84 | 1.35 | 0.19 | 0.44 | 7.64 | 25.49 | 59.73 | |||
AXGN | 2.25 | (0.05) | (0.01) | 0.06 | 3.80 | 4.73 | 21.60 | |||
AIMD | 3.71 | (0.57) | 0.00 | (0.29) | 0.00 | 8.16 | 28.01 | |||
LNSR | 3.48 | 0.81 | 0.17 | 1.29 | 3.84 | 8.92 | 23.28 |
Icad Corporate Management
Jonathan Go | Sr. VP of RandD | Profile | |
Eric Lonnqvist | Chief Officer | Profile | |
Annette Heroux | Vice Administration | Profile | |
Stephen Sarno | Interim Officer | Profile | |
Michelle Strong | Chief Officer | Profile | |
Brian Testa | Chief Officer | Profile |